what was your issue with that? I took away that they clearly know who the players in the wound care area are and are in communication with them. this seems a good thing to me?
looking forward to the results, judging by the comments there is a definite sense of uncertainty or concern of what will happen in the event that the trial is not successful. these concerns are natural and sensible, but once the trial is done I believe the ema approval (finally) should have a very high probability, and also a good chance of a partner for vlus phase 3. if the pilot trial in DFU is a success I think they will be acquired.
- Forums
- ASX - By Stock
- DLM
- for what purpose?
for what purpose?, page-18
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online